Bouvard, V, et al.
A review of human carcinogens – Part B: biological agents. Lancet Oncology
2009; 10: 321–322.
de Sanjose, S, et al.
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncology
2010; 11: 1048–1056.
Li, N, et al.
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. International Journal of Cancer
2011; 128: 927–935.
Smith, JS, et al.
Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. International Journal of Cancer
2007; 121: 621–632.
Hariri, S, et al.
Human papillomavirus genotypes in high-grade cervical lesions in the United States. Journal of Infectious Diseases
2012; 206: 1878–1886.
Hamzi, Abdul Raub S, et al.
Distribution of HPV genotypes in cervical cancer in multi- ethnic Malaysia. Asian Pacific Journal of Cancer Prevention
2014; 15: 651–656.
General Bureau of Statistics. The Eighth Population and Housing Census in Suriname (volume I): Demographic and Social Characteristics and Migration. Suriname, 2013.
Greer, CE, Wheeler, CM, Manos, MM. Sample preparation and PCR amplification from paraffin-embedded tissues. PCR Methods and Applications
1994; 3: S113–S122.
Sotlar, K, et al.
Detection and typing of human papillomavirus by E6 nested multiplex PCR. Journal of Clinical Microbiology
2004; 42: 3176–3184.
Muñoz, N, et al.
Against which human papillomavirus types shall we vaccinate and screen? The international perspective. International Journal of Cancer
2004; 111: 278–285.
Krul, EJ, et al.
Cervical carcinoma in Surinam. Incidence and staging of cervical carcinoma between 1989 and 1994. Cancer
1996; 77: 1329–1333.
Arbyn, M, et al.
Worldwide burden of cervical cancer in 2008. Annals of Oncology
2011; 22: 2675–2686.
Bosch, FX, et al.
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. Journal of the National Cancer Institute
1995; 87: 796–802.
Ciapponi, A, et al.
Type-specific HPV prevalence in cervical cancer and high-grade lesions in Latin America and the Caribbean: systematic review and meta-analysis. PLoS ONE
2011; 6: e25493.
Insinga, RP, et al.
A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal and vulvar pre-cancers and cancers in the United States. Cancer Epidemiology, Biomarkers & Prevention
2008; 17: 1611–1622.
Halec, G, et al.
Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer. International Journal of Cancer
2013; 132: 63–71.
Ndiaye, C, et al.
Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences?
Tropical Medicine & International Health
2012; 17: 1432–1440.
Sebbelov, AM, et al.
Comparison of human papillomavirus genotypes in archival cervical cancer specimens from Alaska natives, Greenland natives and Danish Caucasians. Microbes and Infection
2000; 2: 121–126.
Roa, SJC, et al.
Microsatellite instability and human papilloma virus genotypes in preneoplastic and neoplastic uterine cervix lesions. Revista Médica de Chile
2007; 135: 37–44.
Attoh, S, et al.
Human papilloma virus genotypes in Ghanaian women with cervical carcinoma. East African Medical Journal
2010; 87: 345–349.
Nagai, Y, et al.
Detection of human papillomavirus DNA in primary and metastatic lesions of carcinoma of the cervix in women from Okinawa, Japan. American Journal of Clinical Oncology
2001; 24: 160–166.
de Boer, MA, et al.
Human papillomavirus type 16 E6, E7, and L1 variants in cervical cancer in Indonesia, Suriname, and The Netherlands. Gynecologic Oncology
2004; 94: 488–494.
Geraets, DT, et al.
Cross-sectional study of genital carcinogenic HPV infections in Paramaribo, Suriname: prevalence and determinants in an ethnically diverse population of women in a pre-vaccination era. Sexually Transmitted Infections
Moustafa, AE Al, et al.
High-risk HPVs and human carcinomas in the Syrian population. Frontiers in Oncology
2014; 4: 68.
Alemany, L, et al.
Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007. International Journal of Cancer
2014; 135: 88–95.
Powell, N, et al.
Cervical cancers associated with human papillomavirus types 16, 18 and 45 are diagnosed in younger women than cancers associated with other types: a cross-sectional observational study in Wales and Scotland (UK). Journal of Clinical Virology
2013; 58: 571–574.
Guardado-Estrada, M, et al.
The distribution of high-risk human papillomaviruses is different in young and old patients with cervical cancer. PLoS ONE. Published online: 8 October 2014. doi:10.1371/journal.pone.0109406.
Murillo, R, et al.
HPV prevalence in Colombian women with cervical cancer: Implications for vaccination in a developing country. Infectious Diseases in Obstetrics and Gynecology. Published online: 20 December 2009. doi:10.1155/2009/653598.
Bänffer, JR, et al.
The epidemiology of hepatitis B infections in a poly-ethnic population. American Journal of Epidemiology
1977; 106: 507–511.
Zehbe, I, et al.
Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Research
1998; 58: 829–833.
Bhatla, N, et al.
Human papillomavirus type distribution in cervical cancer in Delhi, India. International Journal of Gynecological Pathology
2006; 25: 398–402.
De Boer, MA, et al.
Human papillomavirus type 18 variants: histopathology and E6/E7 polymorphisms in three countries. International Journal of Cancer
2005; 114: 422–425.
Goldie, SJ, et al.
Mathematical models of cervical cancer prevention in Latin America and the Caribbean. Vaccine
2008; 26 (Suppl. 11): L59–L72.
Bogaards, JA, et al.
Long-term impact of human papillomavirus vaccination on infection rates, cervical abnormalities, and cancer incidence. Epidemiology (Cambridge, Mass.)
2011; 22: 505–515.